Human papillomaviruses and carcinogenesis of the uterine cervix: Future prospects for the detection and prevention of precursor lesions;Papillomavirus humains et carcinogenèse du col utérin: Perspectives dans les domaines du dépistage et de la prévention

Bulletin de l'Academie Nationale de Medecine

Volumn 181, Issue 7, 1997, Pages 1365-1394

  Orth, Gérard ^b   Croissant, Odile ^a  

^a INSTITUT PASTEUR   (France)

^b NONE

Author keywords

Cervix neoplasms, prevention and control; Papillomavirus, Human; Vaccines

Indexed keywords

DISEASE TRANSMISSION; FEMALE; HUMAN; ISOLATION AND PURIFICATION; PAPILLOMA VIRUS; REVIEW; UTERINE CERVIX TUMOR; VIROLOGY; VIRUS INFECTION;

FEMALE; HUMANS; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; TUMOR VIRUS INFECTIONS; UTERINE CERVICAL NEOPLASMS;

EID: 2442707993     PISSN: 00014079     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (114)

1. ALEXANDER M., SALGALLER M. L., CELIS E. et al. - Generation of tumor -specific cytolytic T lymphocytes from peripheral blood of cervical cancer patients by in vitro stimulation with a synthetic human papillomavirus type 16 E7 epitope. Am J Obstet Gynecol, 1996, 175, 1586 -1593.
2. ALLOUB M. I., BARR B.B.B., MCLAREN K.M. et al. - Human papillomavirus infection and cervical intraepithelial neoplasia in women with renal allografts. Br Med J, 1989, 298, 153 -156.
3. APPLE R. J., ERLICH H.A., KLITZ W. et al. - HLA DR -DQ associations with cervical carcinoma show papillomavirus -type specificity. Nature Genet, 1994, 6, 157 -162.
4. AYNAUD O., TRANBALOC P., ORTH G. - Lack of evidence for a role of human papillomaviruses in transitional cell carcinoma of the urinary bladder. J Urol, 1998, 159, sous presse.
5. BARRASSO R., DE BRUX J., CROISSANT O., ORTH G. - High prevalence of human papillomavirus -associated penile intraepithelial neoplasia in sexual partners of women with cervical intraepithelial neoplasia. N Engl J Med, 1987, 577, 916 -923.
6. BAUER H. M., TING Y., GREER C.E. et al. - Genital human papillomavirus infection in female university students as determined by a PCR -based method. J Am Med Assoc, 1991, 205, 472 -477.
7. BAUER H. M., HILDESHEIM A., SCHIFFMAN M.H. et al. - Determinants of genital human papillomavirus infection in low -risk women in Portland, Oregon. Sex Transm Dis, 1993, 20, 274 -278.
8. BERGERON C., BARRASSO R., BEAUDENON S. et al. - Human papillomaviruses associated with cervical intraepithelial neoplasia: Great diversity and distinct distribution in low -and high -grade lesions. Am J Surg Pathol, 1992, 16, 641 -649.
9. BERNARD H. U., CHAN S.Y., MANOS M.M. et al. - Identification and assessment of known and novel human papillomaviruses by polymerase chain reaction amplification, restriction fragment length polymorphisms, nucleotide sequence, and phylogenetic algorithms. J Infect Dis, 1994, 170, 1077 -1085.
10. BORYSIEWIEZ L. K., FIANDER A., NIMAKO M. et al. - A recombinant vaccinia virus encoding human papillomavirus types 16 and 18, E6 and E7 proteins as immunotherapy for cervical cancer. Lancet, 1996, 347, 1523 -1527.
11. BOSCH F. X., MANOS M.M., MUÑOZ N. et al. - Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. J Natl Cancer Inst, 1995, 87, 796 -802.
12. BOSCH F. X., CASTELLSAGUE X., MUÑOZ N. et al. - Male sexual behavior and human papillomavirus DNA: Key risk factors for cervical cancer in Spain. J Natl Cancer Inst, 1996, 88, 1060 -1067.
13. BOURHIS J., LÊ M. G., BARROIS M. et al. - Prognostic value of c -myc proto -oncogene overexpression in early invasive carcinoma of the cervix. J Clin Oncol, 1990, 8, 1789 -1796.
14. BREITBURD F., KIRNBAUER R., HUBBERT N.L. et al. - Immunization with viruslike particles from cottontail rabbit papillomavirus (CRPV) can protect against experimental CRPV infection. J Virol, 1995, 69, 3959 -3963.
15. BREITBURD F., RAMOZ N., SALMON J., ORTH G. - HLA control in the progression of human papillomavirus infections. Semin Cancer Biol, 1996, 7, 359 -371.
16. BREITBURD F., SALMON J., ORTH G. - Animal models for evaluation of human papillomavirus vaccines. In: E.L. Franco J. Monsonego. New Developments in Cervical Cancer Screening and Prevention, Oxford, UK, Blackwell Science Ltd., 1997, 432 -444.
17. BUCKLEY J. D., HARRIS R.W.C., DOLL R. et al. - Case -control study of the husbands of women with dysplasia or carcinoma of the cervix uteri. Lancet, 1981, 2, 1010 -1015.
18. BURGER M. P. M., HOLLEMA H., PIETERS W.J. L.M. et al. - Epidemiological evidence of cervical intraepithelial neoplasia without the presence of human papillomavirus. Br J Cancer, 1996, 73, 831 -836.
19. BURK R. D., Ho G.Y.F., BEARDSLEY L. et al. - Sexual behavior and partner characteristics are the predominant risk factors for genital human papillomavirus infection in young women. J Infect Dis, 1996, 174, 679 -689.
20. BURK R. D., KELLY P., FELDMAN J. et al. - Declining prevalence of cervicovaginal human papillomavirus infection with age is independent of other risk factors. Sex Transm Dis, 1996, 23, 333 -341.
21. CAMPO S. - Vaccination against papillomavirus in cattle. Clin Dermatol, 1997, 15, 275 -283.
22. CARTER J. J., GALLOWAY D.A. - Humoral immune response to human papillomavirus infection. Clin Dermatol, 1997, 15, 249 -259.
23. CHANG M. H., CHEN C.J., LAI M.S. et al. - Universal hepatitis B vaccination in Taiwan and the incidence of hepatocellular carcinoma in children. N Engl J Med, 1997, 336, 1855 -1859
24. CHEN T. M., PECORARO G., DEFENDI V. - Genetic analysis of in vitro progression of human papillomavirus -transfected human cervical cells. Cancer Res, 1993, 53, 1167 -1171.
25. CLERICI M., MEROLA M., FERRARIO E. et al. - Cytokine production patterns in cervical intraepithelial neoplasia: Association with human papillomavirus infection. J Natl Cancer Inst, 1997, 89, 245 -250.
26. COLEMAN N., BIRLEY H. D.L., RENTON A.M. et al. - Immunological events in regressing genital warts. Am J Clin Pathol, 1994, 102, 768 -774.
27. COUTURIER J., SASTRE -GARAU X., SCHNEIDER -MAUNOURY S. et al. - Integration of papillomavirus DNA near myc genes in genital carcinomas and its consequences for proto -oncogene expression. J Virol, 1991, 65, 4534 -4538.
28. COX J. T., SCHIFFMAN M.H., WINZELBERG A.J., PATTERSON J.M. - An evaluation of human papillomavirus testing as part of referral to colposcopy clinics. Obstet Gynecol, 1992, 80, 389 -395.
29. COX J. T., LÖRINEZ A.T., SCHIFFMAN M.H. et al. - Human papillomavirus testing by hybrid capture appears to be useful in triaging women with a cytologic diagnosis of atypical squamous cells of undetermined significance. Am J Obstet Gynecol, 1995, 172, 946 -954.
30. CROISSANT O., PELISSIER C., SOPENA B. et al. - Lessons drawn from a follow -up study of genital human papillomavirus infections in immunosuppressed renal allograft recipients, 1998, soumis pour publication.
31. CULLEN A. P., REID R., CAMPION M., LÖRINEZ A.T. - Analysis of the physical state of different human papillomavirus DNAs in intraepithelial and invasive cervical neoplasm. J Virol, 1991, 65, 606 -612.
32. CUZICK J., TERRY G., HO L. et al. - Type -specific human papillomavirus DNA in abnormal smears as a predictor of high -grade cervical intraepithelial neoplasia. Br J Cancer, 1994, 69, 167 -171.
33. CUZICK J., SZAREWSKI A., TERRY G. et al. - Human papillomavirus testing in primary cervical screening. Lancer, 1995, 345, 1533 -1536.
34. DA VIES D. H., STAUSS H.J. - The significance of human leukocyte antigen associations with cervical cancer. Papillomavirus Rep, 1997, 8, 43 -50.
35. DE BRUX J., ORTH G., CROISSANT O. et al. - Lesions condylomateuses du col utérin: évolution chez 2 466 patientes. Bull Cancer, 1983, 70, 410 -422.
36. DILLNER J., LEHTINEN M., BJORGE T. et al. - Prospective seroepidemiologic study of human papillomavirus infection as a risk factor for invasive cervical cancer. J Natl Cancer Inst, 1997, 89, 1293 -1299.
37. EvANDER M., EDLUND K., GUSTAFSSON A. et al. - Human papillomavirus infection is transient in young women: a population -based cohort study. J Infect Dis, 1995, 171, 1026 -1030.
38. FAVRE M., RAMOZ N., ORTH G. - Human papillomaviruses: General features. Clin Dermatol, 1997, 75, 181 -198.
39. FERENCZY A., FRANCO E., ARSENEAU J. et al. - Diagnostic performance of Hybrid Capture human papillomavirus deoxyribonucleic acid assay combined with liquid -based cytologic study. Am J Obstet Gynecol, 1996, 175, 651 -656.
40. FRAZER I. - Strategies for immunoprophylaxis and immunotherapy of papillomaviruses. Clin Dermatol, 1997, 75, 285 -297.
41. GROSS G. E., BARRASSO R. - Human papilloma virus infection. A clinical atlas. Berlin, Ullstein Mosby, 1997.
42. HEARD I., BERGERON C., JEANNEL D. et al. - Papanicolaou smears in human immunodeficiency virus -seropositive women during follow -up. Obstet Gynecol, 1995, 86, 749 -753.
43. HIGGINS G. D., DAVY M., RODER D. et al. - Increased age and mortality associated with cervical carcinomas negative for human papillomavirus RNA. Lancet, 1991, 338, 910 -913.
44. HILDESHEIM A., SCHIFFMAN M. H., GRAVITT P.E. et al. - Persistence of type -specific human papillomavirus infection among cytologically normal women. J Infect Dis, 1994, 169, 235 -240.
45. HO G. Y. F., BURK R.D., KLEIN S. et al. - Persistent genital human papillomavirus infection as a risk factor for persistent cervical dysplasia. J Natl Cancer Inst, 1995, 87, 1365 -1371.
46. HOWLEY P. M. - Papillomaviridae: The viruses and their replication. In: B.N. Fields, D.M. Knipe P.M. Howley. Virology, Philadelphia, Lippincott -Raven, 1996, 2045 -2076.
47. IARC Working Group on the Evaluation of Carcinogenic Risks to Humans - Human Papillomaviruses. Lyon, France, IARC, 1995.
48. JACOBS M. V., SNIJDERS P.J.F., VAN DEN BRULE A.J.C. et al. - A general primer GP5+/GP6 ± mediated PCR -enzyme immunoassay method for rapid detection of 14 high -risk and 6 low -risk human papillomavirus genotypes in cervical scrapings. J Clin Microbiol, 1997, 35, 791 -795.
49. JENKINS D., SHERLAW -JOHNSON C., GALLIVAN S. - Can papilloma virus testing be used to improve cervical cancer screening ? Int J Cancer, 1996, 65, 768 -773.
50. KAST W. M., FELTKAMP M.C.W., RESSING M.E. et al. - Cellular immunity against human papillomavirus associated cervical cancer. Semin Virol, 1996, 7, 117 -123.
51. KATAJA V., SYRJANEN S., MANTYMRVI R. et al. - Prognostic factors in cervical human papillomavirus infections. Sex Transm Dis, 1992, 19, 154 -160.
52. KAYE J. N., STARKEY W.O., KELL B. et al. - Human papillomavirus type 16 in infants: use of DNA sequence analyses to determine the source of infection. J Gen Virol, 1996, 77, 1139 -1143.
53. KIRNBAUER R., HUBBERT N. L., WHEELER C.M. et al. - A virus -like particle enzyme -linked immunosorbent assay detects serum antibodies in a majority of women infected with human papillomavirus type 16. J Natl Cancer Inst, 1994, 86, 494 -499.
54. KJÆR S. K., VAN DEN BRULE A.J.C., BJOCK J.E. et al. - Human papillomavirus - The most significant risk determinant of cervical intraepithelial neoplasia. Int J Cancer, 1996, 65, 601 -606.
55. KOUTSKY L. A., HOLMES K.K., CRITCHLOW C.W. et al. - A cohort study of the risk of cervical intraepithelial neoplasia grade 2 or 3 in relation to papillomavirus infection. AT Engl J Med, 1992, 527, 1272 -1278.
56. KURMAN R. J., HENSON D.E., HERBST A. L. et al. - Interim guidelines for management of abnormal cervical cytology. JAMA, 1994, 271, 1866 -1869.
57. LEY C., BAUER H. M., REINGOLD A. et al. - Determinants of genital human papillomavirus infection in young women. J Natl Cancer Inst, 1991, 83, 997 -1003.
58. LONDESBOROUGH P., HO L., TERRY G. et al. - Human papillomavirus genotype as a predictor of persistence and development of high -grade lesions in women with minor cervical abnormalities. Int J Cancer, 1996, 69, 364 -368.
59. LONGUET M., CASSONNET P., ORTH G. - A novel genital human papillomavirus (HPV), HPV type 74, found in immunosuppressed patients. J Clin Microbiol, 1996, 34, 1859 -1862.
60. LÖRINCZ A. T., REID R., JENSON A.B. et al. - Human papillomavirus infection of the cervix: Relative risk associations of 15 common anogenital types. Obstet Gynecol, 1992, 79, 328 -337.
61. LÖRINCZ A. - Hybrid capture™ method for detection of human papillomavirus DNA in clinical specimens. Papillomavirus Rep, 1996, 7, 1 -5.
62. MATSUKURA T., SUGASE M. - Identification of genital human papillomaviruses in cervical biopsy specimens: Segregation of specific virus types in specific clinicopathologic lesions. Int J Cancer, 1995, 67, 13 -22.
63. MCDOUGALL J. K. - HPV immortalisation and transformation. In: C. Lacey. Papillomavirus Reviews: Current Research on Papillomaviruses, Leeds, UK, Leeds University Press, 1996, 47 -53.
64. MCINDOE W. A., MCLEAN M.R., JONES R.W., MULLINS P.R. - The invasive potential of carcinoma in situ of the cervix. Obstet Gynecol, 1984, 64, 451 -458.
65. MCNEIL C. - HPV vaccine treatment trials proliferate, diversify. Where the HPV vaccine trials are. J Natl Cancer Inst, 1997, 89, 280 -281.
66. MEISELS A., MORIN C. - Human papillomavirus and cancer of the uterine cervix. Gynecol Oncol, 1981, 12, S111 -S123.
67. MELKERT P. W. J., HOPMAN E., VAN DEN BRULE A.J.C. et al. - Prevalence of HPV in cytomorphologically normal cervical smears, as determined by the polymerase chain reaction, is age -dependent. Int J Cancer, 1993, 53, 919 -923.
68. MUÑOZ N., BOSCH F. X., DE SANJOSE S. et al. - The causal link between human papillomavirus and invasive cervical cancer: a population -based case -control study in Colombia and Spain. Int J Cancer, 1992, 52, 743 -749.
69. MYERS G., BAKER C., WHEELER C. et al. - Human Papillomaviruses 1996. A compilation and analysis of nucleic acid and amino acid sequences. Los Alamos, New Mexico, Los Alamos National Laboratory, 1996.
70. NASIELL K., NASIELL M., VÁCLAVINKOVÁ V. - Behavior of moderate cervical dysplasia during long -term follow -up. Obstet Gynecol, 1983, 61, 609 -614.
71. NASIELL K., ROGER V., NASIELL M. - Behavior of mild cervical dysplasia during long -term follow -up. Obstet Gynecol, 1986, 67, 665 -669.
72. NEILL S. M., LESSANA -LEOBOWITCH M., PELISSE M., MOYAL -BARRACCO M. - Lichen sclerosus, invasive squamous cell carcinoma, and human papillomavirus. Am J Obstet Gynecol, 1990, 162, 1633 -1634.
73. NONNENMACHER B., HUBBERT N. L., KIRNBAUER R. et al. - Serologic response to human papillomavirus type 16 (HPV -16) virus -like particles in HPV -16 DNA -positive invasive cervical cancer and cervical intraepithelial neoplasia grade III patients and controls from Colombia and Spain. J Infect Dis, 1995, 172, 19 -24.
74. OBALEK S., JABLONSKA S., ORTH G. - Anogenital warts in children. Clin Dermatol, 1997, 15, 369 -376.
75. ORIEL J. D. - Natural history of genital warts. Br J Vener Dis, 1971, 47, 1 -13.
76. ORTH G. - Epidermodysplasia verruciformis. In: P.M. Howley N.P. Salzman. The papillomaviruses. New York, Plenum Press, 1987, 199 -243.
77. ORTH G. - Nouvelles perspectives dans le domaine du dépistage précoce et de la prévention des précurseurs des cancers du col de l'utérus. In: Chercher pour agir. Recherche d'aujourd'hui. Médecine d'aujourd'hui et de demain. 2é Colloque CNAMTS -INSERM, Paris, Editions INSERM, 1988, 187, 87 -94.
78. PARK T. W., RICHART R.M., SUN X.W., WRIGHT T.C. - Association between human papillomavirus type and clonal status of cervical squamous intraepithelial lesions. J Natl Cancer Inst, 1996, 88, 355 -358.
79. PORRECO R., PENN I., DROEGEMUELLER W. et al. - Gynecologic malignancies in immunosuppressed organ homograft recipients. Obstet Gynecol, 1975, 45, 359 -364.
80. PURANEN M. H., YLISKOSKI M.H., SAARIKOSKI S.V. et al. - Exposure of an infant to cervical human papillomavirus infection of the mother is common. Am J Obstet Gynecol, 1997, 176, 1039 -1045.
81. REMMINK A. J., WALBOOMERS J.M.M., HELMERHORST T.J.M. et al. - The presence of persistent high -risk HPV genotypes in dysplastic cervical lesions is associated with progressive disease: Natural history up to 36 months. Int J Cancer, 1995, 61, 306 -311.
82. RICHART R. M. - Cervical intraepithelial neoplasia: A review. Pathol Annu, 1973, 8, 301 -328.
83. RICHART R. M. - Screening: The next century. Cancer, 1995, 76, 1919 -1927.
84. RIOU G., HAVRE M., JEANNEL D. et al. - Association between poor prognosis in early -stage invasive cervical carcinomas and non detection of HPV DNA. Lancet, 1990, 335, 1171 -1174.
85. RODEN R. B. S., HUBBERT N.L., KIRNBAUER R. et al. - Assessment of the serological relatedness of genital human papillomaviruses by hemagglutination inhibition. J Virol, 1996, 70, 3298 -3301.
86. ROTKIN I. D. - A comparison review of key epidemiological studies in cervical cancer related to current searches for transmissible agents. Cancer Res, 1973, 33, 1353 -1367.
87. ROZENDAAL L., WALBOOMERS J. M.M., VAN DER LINDEN J.C. et al. - PCR -based high -risk HPV test in cervical cancer screening gives objective risk assessment of women with cytomorphologically normal cervical smears. Int J Cancer, 1996, 68, 766 -769.
88. SASTRE -GARAU X., ASSELAIN B., BERGERON C. et al. - Pathologie précancéreuse et cancéreuse du col de l'utérus. Résultats d'une enqûte conduite par le groupe « Cancers génitaux » de PETRI, dans la région Ile -de -France, de mai 1990 à mai 1992, et portant sur 8 805 biopsies. Bull Cancer, 1996, 83, 400 -406.
89. SCHIFFMAN M. H. - Recent progress in defining the epidemiology of human papillomavirus infection and cervical neoplasia. J Natl Cancer Inst, 1992, 84, 394 -398.
90. SCHIFFMAN M. H., BAUER H.M., HOOVER R.N. et al. - Epidemiologic evidence showing that human papillomavirus infection causes most cervical intraepithelial neoplasia. J Natl Cancer Inst, 1993, 85, 958 -964.
91. SCHIFFMAN M. H., BRINTON L.A. - The epidemiology of cervical carcinogenesis. Cancer, 1995, 76, 1888 -1901.
92. SCHIFFMAN M. H., KIVIAT N.B., BURK R.D. et al. - Accuracy and interlaboratory reliability of human papillomavirus DNA testing by hybrid capture. J Clin Microbiol, 1995, 33, 545 -550.
93. SCHNEIDER A., ZAHM D. M., KIRCHMAYR R., SCHNEIDER V.L. - Screening for cervical intraepithelial neoplasia grade 2/3: Validity of cytologic study, cervicography, and human papillomavirus detection. Am J Obstet Gynecol, 1996, 174, 1534 -1541.
94. SCHNEIDER -MAUNOURY S., CROISSANT O., ORTH G. - Integration of human papillomavirus type 16 DNA sequences: A possible early event in the progression of genital tumors. J Virol, 1987, 61, 3295 -3298.
95. SHAH K. V., HOWKEY P.M. - Papillomaviruses. In: B.N. Fields, D.M. Knipe P.M. Howley. Virology, Philadelphia, Lippincott -Raven, 1996, 2077 -2109.
96. SHAH K. V., SOLOMON L., DANIER R. et al. - Comparison of PCR and hybrid capture methods for detection of human papillomavirus in injection drug -using women at high risk of human immunodeficiency virus infection. J Clin Microbiol, 1997, 35, 517 -519.
97. SHERMAN M. E., SCHIFFMAN M.H., LÖRINCZ A.T. et al. - Toward objective quality assurance in cervical cytopathology. Correlation of cytopathologic diagnoses with detection of high -risk human papillomavirus types. Am J Clin Pathol, 1994, 102, 182 -187.
98. SIGURDSSON K., ARNADOTTIR T., SNORRADOTTIR M. et al. - Human papillomavirus (HPV) in an Icelandic population: The role of HPV DNA testing based on hybrid capture and PCR assays among women with screen -detected abnormal pap smears. Int J Cancer, 1997, 72, 446 -452.
99. SMITS H. L., BOLLEN L.J.M., TJON -A -HUNG S.P. et al. - Intermethod variation in detection of human papillomavirus DNA in cervical smears. J Clin Microbiol, 1995, 33, 2631 -2636.
100. SOLOMON D. - Pap test abnormalities by diagnosis. J Natl Cancer Inst, 1997, 89, 475.
101. STERN P. L. - Immunity to human papillomavirus -associated cervical neoplasia. Adv Cancer Res, 1996, 69, 175 -211.
102. SUN X. W., ELLERBROCK T.V., LUNGU O. et al. - Human papillomavirus infection in human immunodeficiency virus -seropositive women. Obstet Gynecol, 1995, 85, 680 -686.
103. SUZICH J. A., GHIM S. -J., PALMER -HILL F.J. et al. - Systemic immunization with papillomavirus LI protein completely prevents the development of viral mucosal papillomas. Proc Natl Acad Sci USA, 1995, 92, 11553 -11557.
104. THOMAS D. B. - An epidemiologic study of carcinoma in situ and squamous dysplasia of the uterine cervix. Am J Epidemiol, 1973, 98, 10 -28.
105. VAN DEN BRULE A. J. C., SNIJDERS P.J.F., MEIJER C.J.L.M., WALBOOMERS J.M.M. - PCR -based detection of genital HPV genotypes: an update and future perspectives. Papillomavirus Rep, 1993, 4, 95 -99.
106. VERMUND S. H., MELNICK S.L. - Human Papillomavirus Infection. In: H.L. Minkoff, J.A. DeHovitz A. Duerr. HIV Infection in Women, New York: Raven Press, Ltd, 1995, 189 -227.
107. VISCIDI R. P., SUN Y., TSUZAKI B. et al. - Serologic response in human papillomavirus -associated invasive cervical cancer. Int J Cancer, 1993, 55, 780 -784.
108. WALBOOMERS J. M. M., DE RODA HUSMAN A.M., VAN DEN BRULE A.J.C. et al. - Detection of genital human papillomavirus infections: critical review of methods and prevalence studies in relation to cervical cancer. In: P.L. Stern, M. Stanley. Human pathogenic papillomaviruses and cervical cancer, New York: Oxford University Press, 1994, 41 -71.
109. WALBOOMERS J. M. M., MEUER C.J.L.M. - Do HPV -negative cervical carcinomas exist? J Pathol, 1997, 181, 253 -254.
110. WANK R., THOMSSEN C. - High risk of squamous cell carcinoma of the cervix for women with HLA -DQw3. Nature, 1991, 352, 723 -725.
111. WRIGHT T. C., ELLERBROCK T.V., CHIASSON M.A. et al. - Cervical intraepithelial neoplasia in women infected with human immunodeficiency virus: prevalence, risk factors, and validity of Papanicolaou smears. Obstet Gynecol, 1994, 84, 591 -597.
112. WRIGHT T. C., KURMAN R.J. - A critical review of the morphologic classification systems of preinvasive lesions of the cervix: The scientific basis for shifting the paradigm. In: C. Lacey. Papillomavirus Reviews: Current Research on Papillomaviruses, Leeds, UK, Leeds University Press, 1996, 215 -225.
113. XI L. F., KOUTSKY L.A., GALLOWAY D.A. et al. - Genomic variation of human papillomavirus type 16 and risk for high grade cervical intraepithelial neoplasia. J Natl Cancer Inst, 1997, 89, 796 -802.
114. ZUR HAUSEN H. - Papillomavirus infections: A major cause of human cancers. Biochim Biophys Acta, 1996, 1288, F55 -F78.